Olenox Acquires Psylinks Neurotech for $500K in Stock, Adds AI/Neurotech Capabilities
OLOX sits 32% above its 52-week low of $4.1.
Summary
Olenox Industries acquired Psylinks Neurotech Corp. for $500,000 in restricted stock, adding neurotechnology and AI capabilities. The deal includes hiring two PhDs as VPs and is a related party transaction approved by the board with the Chairman abstaining.
Key Events · M&A and Partnerships · OLOX
-
Acquisition of Psylinks Neurotech
Olenox acquired 100% of Psylinks Neurotech Corp., an Alberta-based neurotechnology and applied intelligence company, for $500,000 in restricted common stock (104,166 shares at $4.80/share).
-
Key Hires from Psylinks
Dr. Ford Burles, PhD, joins as VP of Product Development and Dr. Michael McLaren-Gradinaru, PhD, as VP of Technology, bringing expertise in neuroscience, AI, and machine learning.
-
Related Party Transaction
The acquisition is a related party transaction due to a familial relation between a seller and Olenox's Chairman, Michael McLaren, who abstained from the board vote approving the deal.
-
Strategic Diversification
The deal expands Olenox into neurotechnology and AI, complementing its recent entry into Bitcoin mining via the CS Digital Ventures acquisition, though the purchase price is modest at $500K.
Analysis · OLOX · Trade & Services
Olenox Industries acquired Psylinks Neurotech Corp., a neurotechnology and applied intelligence company, for $500,000 in restricted stock (104,166 shares at $4.80/share). The deal brings on key talent: Dr. Ford Burles as VP of Product Development and Dr. Michael McLaren-Gradinaru as VP of Technology. The acquisition is a related party transaction due to a familial relationship between a seller and Olenox's Chairman, who abstained from the board vote. While the purchase price is modest relative to Olenox's recent $30M CS Digital Ventures acquisition, it signals a strategic push into AI-driven neurotech, diversifying beyond energy and Bitcoin mining. The stock consideration at $4.80 per share represents a discount to the current $5.42 price, but the restricted nature and small size limit immediate dilution. Given Olenox's going concern warning and material weaknesses disclosed in its recent 10-K, this acquisition could be seen as a low-cost bet on future growth, though integration risks and the related party nature warrant scrutiny.
How filings like this one have moved
In the 30 days to Aug 24, 2026, 29.4% of the 2796 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.03%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OLOX was trading at $5.42 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $7.1M. The 52-week trading range was $4.10 to $437.06. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.